Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Education

Research Leaders

5 sponsors active, led by China-Japan Friendship Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Education1
  • Bariatric Surgery1
  • Nonsurgical Therapy1

Active Sponsors

  • China-Japan Friendship Hospital1
  • Tartu University Hospital1
  • The Scientific and Technological Research Council of Turkey1
  • Balikesir University1
  • University of Campinas, Brazil1

Top Investigators

Related Conditions

  • Diabetic Nephropathy1
  • Metabolic Surgery1
  • Education Of Patients1

Activity Timeline